These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

730 related articles for article (PubMed ID: 27302078)

  • 1. Risk Factors for Local Recurrence and Optimal Length of Esophagectomy in Esophageal Squamous Cell Carcinoma.
    Kang CH; Hwang Y; Lee HJ; Park IK; Kim YT
    Ann Thorac Surg; 2016 Oct; 102(4):1074-80. PubMed ID: 27302078
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment outcome and prognosis of patients with lymph node recurrence of thoracic esophageal squamous cell carcinoma after curative resection.
    Kosuga T; Shiozaki A; Fujiwara H; Ichikawa D; Okamoto K; Komatsu S; Otsuji E
    World J Surg; 2011 Apr; 35(4):798-804. PubMed ID: 21312037
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Patterns of recurrence in patients with stage pT3N0M0 thoracic esophageal squamous cell carcinoma after two-field esophagectomy].
    Wang Y; Wang L; Yang Q; Li J; He M; Yao J; Qi Z; Li B; Qiao X
    Zhonghua Zhong Liu Za Zhi; 2016 Jan; 38(1):48-54. PubMed ID: 26796807
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of the 7th edition of the TNM classification in patients with resected esophageal squamous cell carcinoma.
    Wang J; Wu N; Zheng QF; Yan S; Lv C; Li SL; Yang Y
    World J Gastroenterol; 2014 Dec; 20(48):18397-403. PubMed ID: 25561808
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A strategy for supraclavicular lymph node dissection using recurrent laryngeal nerve lymph node status in thoracic esophageal squamous cell carcinoma.
    Taniyama Y; Nakamura T; Mitamura A; Teshima J; Katsura K; Abe S; Nakano T; Kamei T; Miyata G; Ouchi N
    Ann Thorac Surg; 2013 Jun; 95(6):1930-7. PubMed ID: 23642437
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Aggressive surgical resection does not improve survival in operable esophageal squamous cell carcinoma with N2-3 status.
    Zheng YZ; Zhao W; Hu Y; Ding-Lin XX; Wen J; Yang H; Liu QW; Luo KJ; Huang QY; Chen JY; Fu JH
    World J Gastroenterol; 2015 Jul; 21(28):8644-52. PubMed ID: 26229406
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinicopathological parameters predicting recurrence of pT1N0 esophageal squamous cell carcinoma.
    Xue LY; Qin XM; Liu Y; Liang J; Lin H; Xue XM; Zou SM; Zhang MY; Zhang BH; Hui ZG; Zhao ZT; Ren LQ; Zhang YM; Liu XY; Yuan YL; Ying JM; Gao SG; Song YM; Wang GQ; Dawsey SM; Lu N
    World J Gastroenterol; 2018 Dec; 24(45):5154-5166. PubMed ID: 30568392
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Early recurrence and death after esophagectomy in patients with esophageal squamous cell carcinoma.
    Zhu ZJ; Hu Y; Zhao YF; Chen XZ; Chen LQ; Chen YT
    Ann Thorac Surg; 2011 May; 91(5):1502-8. PubMed ID: 21354552
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Recurrence pattern of squamous cell carcinoma of the thoracic esophagus after extended radical esophagectomy with three-field lymphadenectomy.
    Nakagawa S; Kanda T; Kosugi S; Ohashi M; Suzuki T; Hatakeyama K
    J Am Coll Surg; 2004 Feb; 198(2):205-11. PubMed ID: 14759776
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Significance of Microscopically Incomplete Resection Margin After Esophagectomy for Esophageal Cancer.
    Markar SR; Gronnier C; Duhamel A; Pasquer A; Théreaux J; Chalret du Rieu M; Lefevre JH; Turner K; Luc G; Mariette C;
    Ann Surg; 2016 Apr; 263(4):712-8. PubMed ID: 26135681
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of Positive Margins on Survival in Patients Undergoing Esophagogastrectomy for Esophageal Cancer.
    Javidfar J; Speicher PJ; Hartwig MG; D'Amico TA; Berry MF
    Ann Thorac Surg; 2016 Mar; 101(3):1060-7. PubMed ID: 26576752
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Predictive value of log odds of positive lymph nodes for the prognosis of patients with node-negative squamous cell carcinoma of the thoracic esophagus after radical esophagectomy].
    Yang M; Zhang H; Huo X; Chen C; Yu Z
    Zhonghua Wei Chang Wai Ke Za Zhi; 2016 May; 19(5):535-9. PubMed ID: 27215521
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Predictors of long-term survival after resection of esophageal carcinoma with nonregional nodal metastases.
    Lee PC; Port JL; Paul S; Stiles BM; Altorki NK
    Ann Thorac Surg; 2009 Jul; 88(1):186-92; discussion 192-3. PubMed ID: 19559222
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Safety and benefit of curative surgical resection for esophageal squamous cell cancer associated with multiple primary cancers.
    Otowa Y; Nakamura T; Takiguchi G; Yamamoto M; Kanaji S; Imanishi T; Oshikiri T; Suzuki S; Tanaka K; Kakeji Y
    Eur J Surg Oncol; 2016 Mar; 42(3):407-11. PubMed ID: 26733367
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Survival analysis of patients with stage II squamous cell carcinoma of the thoracic esophagus after esophagectomy].
    Zhang DK; Su XD; Lin P
    Ai Zheng; 2008 Feb; 27(2):113-8. PubMed ID: 18279605
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The recurrence pattern of esophageal carcinoma after transhiatal resection.
    Hulscher JB; van Sandick JW; Tijssen JG; Obertop H; van Lanschot JJ
    J Am Coll Surg; 2000 Aug; 191(2):143-8. PubMed ID: 10945357
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Recurrence pattern of histological node-negative squamous cell carcinoma of the thoracic esophagus after extended radical esophagectomy with lymphadenectomy].
    Guo XF; Fang WT; Mao T; Gu ZT; Yang Y; Chen WH
    Zhonghua Wai Ke Za Zhi; 2013 Oct; 51(10):908-11. PubMed ID: 24433770
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical study on lymph node metastatic recurrence in patients with N0 esophageal squamous cell cancer.
    Sun ZG; Wang Z
    Dis Esophagus; 2011 Apr; 24(3):182-8. PubMed ID: 21073618
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Outcomes of cervical lymph node recurrence in patients with esophageal squamous cell carcinoma after esophagectomy with 2-field lymph node dissection.
    Lee DH; Kim HR; Kim DK; Park SI; Kim YH
    J Thorac Cardiovasc Surg; 2013 Aug; 146(2):365-71. PubMed ID: 23422046
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A second malignancy is the major cause of death among thoracic squamous cell esophageal cancer patients negative for lymph node involvement.
    Sato Y; Motoyama S; Maruyama K; Okuyama M; Ogawa J
    J Am Coll Surg; 2005 Aug; 201(2):188-93. PubMed ID: 16038814
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 37.